Monica Banez-Coronel

Monica Banez-Coronel

Auto-generated profile, based on publicly available information

Monica Banez-Coronel

Center for NeuroGenetics, University of Florida, Gainesville, FL 32610, USA; Department of Molecular Genetics and Microbiology, College of Medicine, University of Florida, Gainesville, FL 32610, USA

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 October 2016 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
LRLaura Rue
Laura Rue
MBMónica Bañez-Coronel
Mónica Bañez-Coronel
JCJordi Creus-Muncunill
Jordi Creus-Muncunill
AGAlbert Giralt
Albert Giralt
RVRafael Alcalá Vida
Rafael Alcalá Vida
EMEulàlia Martí
Eulàlia Martí
Huntington’s disease (HD) is a polyglutamine disorder caused by a CAG expansion in the Huntingtin (HTT) gene exon 1. This expansion encodes a mutant protein whose abnormal function is traditionally associated with HD pathogenesis; however, recent evidence has also linked HD pathogenesis to RNA stable hairpins formed by the mutant HTT expansion. Here, we have shown that a locked nucleic acid–modified antisense oligonucleotide complementary to the CAG repeat (LNA-CTG) preferentially binds to mutant HTT without affecting HTT mRNA or protein levels. LNA-CTGs produced rapid and sustained improvement of motor deficits in an R6/2 mouse HD model that was paralleled by persistent binding of LNA-CTG to the expanded HTT exon 1 transgene. Motor improvement was accompanied by a pronounced recovery in the levels of several striatal neuronal markers severely impaired in R6/2 mice. Furthermore, in R6/2 mice, LNA-CTG blocked several pathogenic mechanisms caused by expanded CAG RNA, including small RNA toxicity and decreased Rn45s expression levels. These results suggest that LNA-CTGs promote neuroprotection by blocking the detrimental activity of CAG repeats within HTT mRNA. The present data emphasize the relevance of expanded CAG RNA to HD pathogenesis, indicate that inhibition of HTT expression is not required to reverse motor deficits, and further suggest a therapeutic potential for LNA-CTG in polyglutamine disorders.

19 December 2025 in Cell Reports
Verified
Journal Article
Open access
MBMonica Banez-Coronel
Monica Banez-Coronel
TZTao Zu
Tao Zu
MAMadeline Aldridge
Madeline Aldridge
SGShu Guo
Shu Guo
RARamadan Ajredini
Ramadan Ajredini
LRLaura P.W. Ranum
Laura P.W. Ranum
Determining if repeat-associated non-AUG (RAN) proteins contribute to the CAG-polyglutamine (polyGln)-encoding spinocerebellar ataxias (CAG-SCAs) is critical for understanding disease mechanisms and for therapy development. Immunohistochemistry shows that sense polyserine (polySer) (AGC frame) and antisense polyleucine (polyLeu) (CUG frame) RAN protein aggregates accumulate throughout the cerebellum and pons, in SCA1, SCA2, SCA3, SCA6, and SCA7 autopsy brains, and in damaged neurons. Cerebellar white matter regions, with prominent polySer and polyLeu but minimal polyGln, show neuroinflammation and demyelination. In SCA3 mice, RAN protein aggregates increase with age. SCA1 Pcp2-ATXN1[82Q] (Pcp2-82Q) mice designed to express ataxin-1 (ATXN1)-polyGln in Purkinje cells show sense and antisense RAN protein aggregates throughout the cerebellum. Disrupting the ATXN182Q:capicua binding, which improves behavior and neuropathology, also reduces RAN protein aggregates. In neural cells, toxic polySer and polyLeu proteins impair autophagy, and reducing RAN protein levels with metformin reduces cytotoxicity. These data identify sense and antisense RAN proteins as a common molecular mechanism shared by the CAG-SCAs.